Insight Public Affairs
We are an award winning 15-strong team of consultants able to offer extensive experience in politics, government, media and stakeholder engagement, across a breadth of policy areas including telecoms, technology, gambling, life sciences, financial services, housing, infrastructure, copyright, employment, media and advertising, food and drink, social care, retail, and education. As an independent agency we go that extra mile to deliver results-focussed communications strategies and programmes that fulfil our clients’ commercial imperatives. Working tirelessly to meet our clients’ goals, we are a team who understand client challenges, develop bespoke strategies and programmes, and meet these strategic objectives.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Visions4Health
Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…
Company Details
Latest Content from PMHub
Cuttsy+Cuttsy becomes employee owned
Press Releases | February 9, 2026 | Cuttsy + Cuttsy
Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.
New Webinar: 2026 Engagement Strategies For Modern Pharma
Press Releases | February 5, 2026 | Impetus Digital
Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!
Why Sleep Health is the Missing Link in Women’s Wellness
Press Releases | February 5, 2026 | Medscape Education
While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...
MFN Pricing Is Moving Fast – Here’s What Matters
Press Releases | February 3, 2026 | Genesis Research Group
With GENEROUS, GUARD, and GLOBE all released since December, 185 pages of policy will materially impact U.S. drug pricing — and yes, it's a lot to digest. In a new...
ISPOR’s 2026–2027 HEOR Trends report: The Era of Evidence Judgment
Press Releases | January 27, 2026 | Genesis Research Group
In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that we’re no longer being evaluated on our ability to produce data, but on...
First impressions matter: Why getting your onboarding right is key for digital engagement
Press Releases | January 20, 2026 | Graphite Digital
As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs not only meet regulatory standards,...
How can pharma build genuine partnerships with patient communities?
White Papers and Resources | January 19, 2026 | Amiculum
Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines development, driving better outcomes, equity...
How will AI change field training?
White Papers and Resources | January 15, 2026 | Inizio
Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...
The Heart and Mouth Connection Every Woman Needs to Know
Press Releases | January 9, 2026 | Medscape Education
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...
Inizio Ignite Sparks a New Era of Connected Advisory Solutions
Press Releases | January 7, 2026 | Inizio
Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.